Landos Biopharma, Inc. Profile Avatar - Palmy Investing

Landos Biopharma, Inc.

Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic c…

Biotechnology
US, Blacksburg [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of LABP's Analysis
CIK: 1785345 CUSIP: 515069102 ISIN: US5150692011 LEI: - UEI: -
Secondary Listings
LABP has no secondary listings inside our databases.